Table 1 Subject characteristics
Subject Characteristics | n = 120 |
|---|---|
Age (years), median (IQR) | 31 (24–37) |
Gender, n(%) | |
Women | 120 (100%) |
Marital Status | |
Married | 63 (52.5%) |
Unmarried | 53 (44.2%) |
Divorced | 4 (3.3%) |
Steroid dose (mg/week), median (IQR) | 16 mg (0–28 mg) |
Lupus activity (MEX SLEDAI), median (IQR) | 6 (0–11) |
HADS A score (Anxiety) | |
Mild (8–10) | 27 (22,5%) |
Moderate (11–15) | 15 (12,5%) |
Severe (16–21) | 1 (0,1%) |
HADS D score (Depression) | |
Mild (8–10) | 24 (20%) |
Moderate (11–15) | 9 (7%) |
Severe (16–21) | 1 (0,1%) |
Organ Involvement, n (%) | |
Mucocutaneous | 116 (96%) |
Musculoskeletal | 114 (95%) |
Hematology | 58 (48%) |
Kidney | 61(50%) |
Serositis | 6 (5%) |
DMARD | |
Azathioprine | 22 (18%) |
Cyclosporine | 9 (7%) |
HCQ | 87 (72%) |
Mycophenolate | 66 (55%) |
MTX | 0 (0%) |
Tacrolimus | 1(0.8%) |
Complement | |
C3 < 90 | 48 (40%) |
C4 < 12 | 15 (12.5%) |